Plasma Trimethylamine-N-oxide following Cessation of L-carnitine Supplementation in Healthy Aged Women

被引：15

作者：

Samulak, Joanna J. ^{[1
]}

Sawicka, Angelika K. ^{[1
]}

Samborowska, Emilia ^{[2
]}

Olek, Robert A. ^{[1
]}

机构：

[1] Gdansk Univ Phys Educ & Sport, Fac Rehabil & Kinesiol, Dept Bioenerget & Nutr, Gorskiego 1, PL-80336 Gdansk, Poland

[2] Polish Acad Sci, Inst Biochem & Biophys, Mass Spectrometry Lab, Pawinskiego 5a, PL-02106 Warsaw, Poland

来源：

NUTRIENTS | 2019年 / 11卷 / 06期

关键词：

cardiovascular disease; endothelial dysfunction; atherosclerosis; cholesterol; leukocytes; MICROBIOTA METABOLISM; RISK; TMAO; MEAT; PHOSPHATIDYLCHOLINE; EPIDEMIOLOGY; DISEASE;

D O I：

10.3390/nu11061322

中图分类号：

R15 [营养卫生、食品卫生]; TS201 [基础科学];

学科分类号：

100403 ;

摘要：

L-carnitine supplementation elevates plasma trimethylamine-N-oxide (TMAO), which may participate in atherosclerosis development by affecting cholesterol metabolism. The aim of the current study was to determine the effect of increased plasma TMAO on biochemical markers in the blood following cessation of L-carnitine supplementation. The follow-up measurements were performed on subjects who completed 24 weeks of L-carnitine or placebo supplementation protocol. Blood samples were taken after finishing the supplementation and then 4 and 12 months following the supplementation withdrawal. Four months after cessation of L-carnitine supplementation, plasma TMAO concentration reached a normal level which was stable for the following eight months. During this period, no modifications in serum lipid profile and circulating leukocyte count were noted. TMAO implications in health and disease is widely discussed. The results of this study demonstrate no adverse effects of elevated plasma TMAO, induced by L-carnitine, on the measured parameters at 4 and 12 months after withdrawal of supplementation.

引用

页数：8

共 50 条

[31] Comparative Genome-Wide Association Studies in Mice and Humans for Trimethylamine N-Oxide, a Proatherogenic Metabolite of Choline and l-Carnitine [J].

Hartiala, Jaana ;

Bennett, Brian J. ;

Tang, W. H. Wilson ;

Wang, Zeneng ;

Stewart, Alexandre F. R. ;

Roberts, Robert ;

McPherson, Ruth ;

Lusis, Aldons J. ;

Hazen, Stanley L. ;

Allayee, Hooman .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34 (06) :1307-1313

[32] Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotic Supplementation [J].

Montrucchio, C. ;

De Nicolo, A. ;

D'Ettorre, G. ;

D'Ascenzo, F. ;

Lazzaro, A. ;

Tettoni, M. ;

D'Avolio, A. ;

Bonora, S. ;

Celani, L. ;

Di Perri, G. ;

Calcagno, A. .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (04)

[33] Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control [J].

Mueller, Daniel M. ;

Allenspach, Martina ;

Othman, Alaa ;

Saely, Christoph H. ;

Muendlein, Axel ;

Vonbank, Alexander ;

Drexel, Heinz ;

von Eckardstein, Arnold .

ATHEROSCLEROSIS, 2015, 243 (02) :638-644

[34] Plasma Trimethylamine-N-Oxide and Incident Ischemic Stroke: The Cardiovascular Health Study and the Multi-Ethnic Study of Atherosclerosis [J].

Lemaitre, Rozenn N. N. ;

Jensen, Paul N. N. ;

Wang, Zeneng ;

Fretts, Amanda M. M. ;

Sitlani, Colleen M. M. ;

Nemet, Ina ;

Sotoodehnia, Nona ;

de Oliveira Otto, Marcia C. C. ;

Zhu, Weifei ;

Budoff, Matt ;

Longstreth, W. T. ;

Psaty, Bruce M. M. ;

Siscovick, David S. S. ;

Hazen, Stanley L. L. ;

Mozaffarian, Dariush .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (16)

[35] Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation [J].

Kuka, Janis ;

Liepinsh, Edgars ;

Makrecka-Kuka, Marina ;

Liepins, Janis ;

Cirule, Helena ;

Gustina, Daina ;

Loza, Einars ;

Zharkova-Malkova, Olga ;

Grinberga, Solveiga ;

Pugovics, Osvalds ;

Dambrova, Maija .

LIFE SCIENCES, 2014, 117 (02) :84-92

[36] Effect of Lactobacillus casei Shirota supplementation on trimethylamine-N-oxide levels in patients with metabolic syndrome: An open-label, randomized study [J].

Tripolt, Norbert J. ;

Leber, Bettina ;

Triebl, Alexander ;

Koefeler, Harald ;

Stadlbauer, Vanessa ;

Sourij, Harald .

ATHEROSCLEROSIS, 2015, 242 (01) :141-144

[37] Trimethylamine-N-Oxide Postprandial Response in Plasma and Urine Is Lower After Fermented Compared to Non-Fermented Dairy Consumption in Healthy Adults [J].

Burton, Kathryn J. ;

Krueger, Ralf ;

Scherz, Valentin ;

Munger, Linda H. ;

Picone, Gianfranco ;

Vionnet, Nathalie ;

Bertelli, Claire ;

Greub, Gilbert ;

Capozzi, Francesco ;

Vergeres, Guy .

NUTRIENTS, 2020, 12 (01)

[38] Simultaneous targeted analysis of trimethylamine-N-oxide, choline, betaine, and carnitine by high performance liquid chromatography tandem mass spectrometry [J].

Liu, Jia ;

Zhao, Mingming ;

Zhou, Juntuo ;

Liu, Changjie ;

Zheng, Lemin ;

Yin, Yuxin .

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2016, 1035 :42-48

[39] Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy [J].

Weiming Liu ;

Chunmin Wang ;

Yu Xia ;

Wei Xia ;

Gaoqin Liu ;

Chi Ren ;

Yu Gu ;

Xin Li ;

Peirong Lu .

Acta Diabetologica, 2021, 58 :221-229

[40] Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy [J].

Liu, Weiming ;

Wang, Chunmin ;

Xia, Yu ;

Xia, Wei ;

Liu, Gaoqin ;

Ren, Chi ;

Gu, Yu ;

Li, Xin ;

Lu, Peirong .

ACTA DIABETOLOGICA, 2021, 58 (02) :221-229

← 1 2 3 4 5 →